8102
-
Biologics: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets and Therapy
(1,101,175) Views
Editor in Chief Dr Doris Mangiaracina Benbrook
1177-5475
Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome
Lars Heslet, Jakob Steen Andersen, Henrik Sengeløv, Björn Dahlbäck, Jorgen Dalsgaard-Nielsen
Biologics: Targets and Therapy 2007, 1:465-472
22 January 2007
The dichloromethane fraction of Stemona tuberosa Lour inhibits tumor cell growth and induces apoptosis of human medullary thyroid carcinoma cells
ZengXia Li, Sonja Sturm, Hermann Stuppner, Elisabeth Schraml, Victor Aguiriano Moser, et al
Biologics: Targets and Therapy 2007, 1:455-463
22 January 2007
Effect of dexamethasone on the IGFBP-1 regulation in premature infants during the first weeks of life
Axel Dost, Eberhard Kauf, Dorothea Schlenvoigt, Dirk Schramm, Felix Zintl, et al
Biologics: Targets and Therapy 2007, 1:449-453
22 January 2007
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches
Peter Valent
Biologics: Targets and Therapy 2007, 1:433-448
22 January 2007
Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS)
David H Dreyfus, S Mark Tompkins, Ramsay Fuleihan, Lucy Y Ghoda
Biologics: Targets and Therapy 2007, 1:425-432
22 January 2007
Tipifarnib in the treatment of acute myeloid leukemia
Xavier Thomas, Mohamed Elhamri
Biologics: Targets and Therapy 2007, 1:415-424
22 January 2007
The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics
Abel D Jarell, Donald Lawrence, Hensin Tsao
Biologics: Targets and Therapy 2007, 1:407-414
22 January 2007
Targeted therapies in the management of metastatic bladder cancer
Matteo Fassan, Edouard J Trabulsi, Leonard G Gomella, Raffaele Baffa
Biologics: Targets and Therapy 2007, 1:393-406
22 January 2007
Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
Madeleine Duvic, Jenny Vu
Biologics: Targets and Therapy 2007, 1:377-392
22 January 2007
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
John S Vorhies, John J Nemunaitis
Biologics: Targets and Therapy 2007, 1:367-376
22 January 2007
Adalimumab in Crohn's disease
Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Biologics: Targets and Therapy 2007, 1:355-365
22 January 2007
Imatinib in the treatment of dermatofibrosarcoma protuberans
Stefanos V Labropoulos, Evangelia D Razis
Biologics: Targets and Therapy 2007, 1:347-353
22 January 2007
Review of erlotinib in the treatment of advanced non-small cell lung cancer
Kristen N Ganjoo, Heather Wakelee
Biologics: Targets and Therapy 2007, 1:335-346
22 January 2007
Targeted therapies in rheumatoid arthritis: Focus on rituximab
YKO Teng, TWJ Huizinga, JM van Laar
Biologics: Targets and Therapy 2007, 1:325-333
22 January 2007
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
